{"id":593126,"date":"2022-03-25T20:48:01","date_gmt":"2022-03-25T20:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=593126"},"modified":"2022-03-25T20:48:01","modified_gmt":"2022-03-25T20:48:01","slug":"stemwave-partners-with-inceler-medikal-as-exclusive-distributor-of-north-america-for-shockwave-products","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/stemwave-partners-with-inceler-medikal-as-exclusive-distributor-of-north-america-for-shockwave-products_593126.html","title":{"rendered":"StemWave Partners with Inceler Medikal As Exclusive Distributor of North America for Shockwave Products"},"content":{"rendered":"<p style=\"text-align: justify;\" dir=\"ltr\"><strong>March 25, 2022 &#8211;<\/strong> StemWave introduces new partnership as the exclusive distributor for North America with global shockwave manufacturer Inceler Medikal. Inceler Medikal is a world-leading shockwave manufacturer and researcher based in Turkey, who has eagerly seeked market access to North America. The StemWave executive team has years of experience in commercialization of shock-wave products and plans to make Incelers products market leaders in North America. <\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">StemWave &amp; Inceler will start by introducing Modus, a focused shockwave device that has been re-engineered for orthopedic application. Modus is one of the only electro-hydraulic shock wave devices available in the US. <\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Focused shockwave devices have shown up to 90% success rates with various chronic musculoskeletal indications. As a state of the art device, Modus plans to achieve similar outcomes with its newly introduced technology. <\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">StemWave will begin distribution to the orthopedic sector on April 1st, 2022.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About StemWave<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">StemWave is committed to rehabilitation accessible to the world by developing revolutionary technology that reshapes traditional healthcare.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/stemwave.com_88945.html\" rel=\"nofollow\">StemWave<\/a><br \/><strong>Contact Person:<\/strong> Helen B.<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=stemwave-partners-with-inceler-medikal-as-exclusive-distributor-of-north-america-for-shockwave-products\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Address:<\/strong>361 Newbury Street  <br \/><strong>City:<\/strong> Boston<br \/><strong>State:<\/strong> MA 02115<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/stemwave.com\/\" target=\"_blank\" rel=\"nofollow\">http:\/\/stemwave.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/stemwave.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=stemwave-partners-with-inceler-medikal-as-exclusive-distributor-of-north-america-for-shockwave-products\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>March 25, 2022 &#8211; StemWave introduces new partnership as the exclusive distributor for North America with global shockwave manufacturer Inceler Medikal. Inceler Medikal is a world-leading shockwave manufacturer and researcher based in Turkey, who has eagerly seeked market access to &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/stemwave-partners-with-inceler-medikal-as-exclusive-distributor-of-north-america-for-shockwave-products_593126.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[417,404],"tags":[],"class_list":["post-593126","post","type-post","status-publish","format-standard","hentry","category-Marketing-Sales","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/593126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=593126"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/593126\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=593126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=593126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=593126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}